Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 1.70% · OPTIONAL
· Electromedical & Electrotherapeutic Apparatus
RESEARCH SNAPSHOTElectromed, Inc.'s latest supported as-filed period reports revenue of $73.8M, 18.4% above the comparable as-filed period; gross margin moved 86 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 1.70% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 13.10% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 15.28% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 4.99% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 78.54% · CORE
Level · gp.fundamentals.operating_margin
Raw value 18.82% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 18.4%; Operating margin moved 663 bp higher; Operating income increased 76.0%.
3 evidence-backed componentsOperating income changed +76.0% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
ELMD · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001437749-26-029618SEC ↗4Sep 3, 2026Period Sep 1, 20260001437749-26-029617SEC ↗8-KAug 25, 2026Period Aug 25, 20260001437749-26-028915SEC ↗10-KAug 25, 2026Period Jun 30, 20260001437749-26-028914SEC ↗4Jul 2, 2026Period Jun 30, 20260001437749-26-022498SEC ↗4Jun 9, 2026Period Jun 8, 20260001437749-26-020030SEC ↗4Jun 8, 2026Period Jun 4, 20260001437749-26-019883SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 1, 2026Filed Sep 3, 2026 | Nagel Bradley M.Chief Financial Officer | Grant Or AwardDirect | 4,900 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Nagel Bradley M.Chief Financial Officer | Grant Or AwardDirect | 9,600 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Nagel Bradley M.Chief Financial Officer | Tax WithholdingDirect | 1,102 | $27 | $29,864 | Form 4 ↗ |
| Jun 30, 2026Filed Jul 2, 2026 | Nagel Bradley M.Chief Financial Officer | Tax WithholdingDirect | 674 | $42 | $28,510 | Form 4 ↗ |
| Jun 8, 2026Filed Jun 9, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 1.78% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 3.69% · OPTIONAL
Operating margin changed +663 basis points from the comparable as-filed period.
Net income changed +58.8% from the comparable as-filed period.
Revenue changed +18.4% from the comparable as-filed period.
Research & development changed +30.3% from the comparable as-filed period.
Gross profit changed +19.7% from the comparable as-filed period.
Gross margin changed +86 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001437749-26-017798| Cunniff James L.CEO and President |
| Open Market SaleDirect |
| 1,026 |
| $38 |
| $38,755 |
| Form 4 ↗ |
| Jun 8, 2026Filed Jun 9, 2026 | Cunniff James L.CEO and President | Option ExerciseDirect | 9,700 | $0 | $0 | Form 4 ↗ |
| Jun 8, 2026Filed Jun 9, 2026 | Cunniff James L.CEO and President | Open Market SaleDirect | 1,671 | $37 | $61,489 | Form 4 ↗ |
| Jun 8, 2026Filed Jun 9, 2026 | Cunniff James L.CEO and President | Open Market SaleDirect | 7,003 | $36 | $253,852 | Form 4 ↗ |
| Jun 8, 2026Filed Jun 9, 2026 | Cunniff James L.CEO and President | Option ExerciseDirect | 9,700 | $17 | $167,325 | Form 4 ↗ |
| Jun 4, 2026Filed Jun 8, 2026 | Nagel Bradley M.Chief Financial Officer | Open Market SaleDirect | 181 | $37 | $6,718 | Form 4 ↗ |
| Jun 4, 2026Filed Jun 8, 2026 | Nagel Bradley M.Chief Financial Officer | Option ExerciseDirect | 4,334 | $0 | $0 | Form 4 ↗ |
| Jun 4, 2026Filed Jun 8, 2026 | Nagel Bradley M.Chief Financial Officer | Option ExerciseDirect | 5,267 | $0 | $0 | Form 4 ↗ |
| Jun 4, 2026Filed Jun 8, 2026 | Nagel Bradley M.Chief Financial Officer | Option ExerciseDirect | 4,334 | $10 | $44,424 | Form 4 ↗ |
| Jun 4, 2026Filed Jun 8, 2026 | Nagel Bradley M.Chief Financial Officer | Option ExerciseDirect | 5,267 | $11 | $56,410 | Form 4 ↗ |
| Jun 4, 2026Filed Jun 8, 2026 | Nagel Bradley M.Chief Financial Officer | Open Market SaleDirect | 11,620 | $36 | $422,219 | Form 4 ↗ |
| May 15, 2026Filed May 19, 2026 | SKARVAN KATHLEENDirector | Open Market SaleDirect | 9,256 | $36 | $335,604 | Form 4 ↗ |
| May 15, 2026Filed May 19, 2026 | SKARVAN KATHLEENDirector | Open Market SaleDirect | 3,562 | $37 | $132,969 | Form 4 ↗ |
| May 15, 2026Filed May 19, 2026 | SKARVAN KATHLEENDirector | Option ExerciseDirect | 40,000 | $0 | $0 | Form 4 ↗ |
| May 15, 2026Filed May 19, 2026 | SKARVAN KATHLEENDirector | Option ExerciseDirect | 40,000 | $4 | $152,800 | Form 4 ↗ |
| May 15, 2026Filed May 19, 2026 | SKARVAN KATHLEENDirector | Open Market SaleDirect | 8,150 | $34 | $280,055 | Form 4 ↗ |